Company Name: Trevena, Inc.

Trevena, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development and discovery of GPCR biased ligands. The company’s product candidates include treatments for:

  • Moderate-to-severe acute pain (intravenous)
  • Moderate-to-severe acute and chronic pain (oral)
  • Acute episodic migraine and other central nervous system disorders
  • Acute heart failure   

Ticker Symbol: TRVN (NASDAQ)

Company Website:

Social Media: Trevena LinkedIn

Headquarters: King of Prussia, PA